Recent ABUS Stock Price | ABUS Stock Predictions | |
$2.75 | +63.64% |
$4.50 |
Recent ABUS Analyst Ratings Breakdown, Making ABUS Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 4 | 4 | 4 | 4 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the ABUS stock predictions from the analysts covering Arbutus Biopharma Corp, we have collected all of the individual ABUS stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 4 different analysts covering ABUS (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since ABUS stock predictions may vary widely, another useful metric to consider is the median ABUS stock prediction, which represents the price at which half of the analysts
made ABUS stock predictions that were higher and half made ABUS stock predictions that were lower. This makes for a different take on the ABUS stock predictions out there, as compared to average or mean.
And that median across all the individual ABUS stock predictions was: $4.5 as of 2024-04-25.
The very highest of the ABUS stock predictions for one year price target was $5.0, while the very lowest of the ABUS stock predictions in the analyst group was
$4.0 (with a standard deviation of $0.577). Get the latest Zacks research report on ABUS — FREE
Find out: ABUS next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
IOSP Stock Predictions
COG Stock Predictions
HOG Stock Predictions
PACB Stock Predictions
RBB Stock Predictions
GTES Stock Predictions
PNTG Stock Predictions
ETRN Stock Predictions
TNC Stock Predictions
|
|
Strong Buy (4.00 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |